N-Nitroso Moxifloxacin Related compound-A
✓
100% accuracy
of data
24/7 scientific
support
⬡
0% tolerance in
quality of product

Stock Locations

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Stock subject to availability.

N-Nitroso Moxifloxacin Related compound-A

● In Stock

Catalogue No.:VE0011337
CAS No.:N/A
Mol. Formula:C20H20F2N4O4
Mol. Weight:418.39 g/mol

Additional information on N-Nitroso Moxifloxacin Related compound-A

Parent drug

Moxifloxacin

IUPAC Name

1-cyclopropyl-6, 8-difluoro-7-((4aS, 7aS)-1-nitrosohexahydro-1H-pyrrolo[3, 4-b]pyridin-6(2H)-yl)-4-oxo-1, 4-dihydroquinoline-3-carboxylic acid

Pharmacopoeial Synonyms

N/A

Other Synonyms

N-Nitroso Moxifloxacin EP Impurity A

Smile

O=C(C1=CN(C2CC2)C3=C(C=C(F)C(N(C4)C[C@]5([H])[C@@]4([H])CCCN5N=O)=C3F)C1=O)O

InChI

InChI=1S/C20H20F2N4O4/c21-14-6-12-17(25(11-3-4-11)8-13(19(12)27)20(28)29)16(22)18(14)24-7-10-2-1-5-26(23-30)15(10)9-24/h6,8,10-11,15H,1-5,7,9H2,(H,28,29)/t10-,15+/m0/s1

Description

N-Nitroso Moxifloxacin Related compound-A Impurity is an N-nitroso derivative of the secondary amine present in Moxifloxacin, which is a highly characterized reference material that meets stringent regulatory standards set for nitrosamine compounds, including those set by USP, EMA, JP, and BP. This nitroso standard is essential for a variety of applications, such as analytical method development, method validation (AMV), and Quality Control (QC), particularly in the context of Moxifloxacin production. It is suitable for use in both Abbreviated New Drug Applications (ANDA) and New Drug Applications (NDA). This nitrosamine standard helps establish detection limits, quantify impurity levels, and ensure trace nitroso impurities in pharmaceutical products remain within FDA and EMA safety limits.

Request a Quote

« * » indique les champs nécessaires

Ce champ n’est utilisé qu’à des fins de validation et devrait rester inchangé.
Products quotation
Name
Url